UK 371804 is an inhibitor of urokinase-type plasminogen activator (uPA; Ki = 10 nM).1 It is 4,000- and 2,700-fold selective for uPA over tissue plasminogen activator (tPA) and plasmin, respectively. UK 371804 inhibits exogenous uPA in human chronic wound fluid (IC50 = 0.89 μM). Topical administration of UK 371804 inhibits exogenous uPA activity in a porcine excisional wound model.
1.Fish, P.V., Barber, C.G., Brown, D.G., et al.Selective urokinase-type plasminogen activator inhibitors. 4. 1-(7-Sulfonamidoisoquinolinyl)guanidinesJ. Med. Chem.50(10)2341-2351(2007)
















